Mittersteiner Mateus, Pereira Genilson S, Wessjohann Ludger A, Bonacorso Helio G, Martins Marcos A P, Zanatta Nilo
Núcleo de Química de Heterociclos (NUQUIMHE), Departamento de Química, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
Department of Bioorganic Chemistry, Leibniz-Institute of Plant Biochemistry, Weinberg 3, 06120 Halle (Saale), Germany.
ACS Omega. 2022 May 24;7(22):18930-18939. doi: 10.1021/acsomega.2c01925. eCollection 2022 Jun 7.
This study reports two strategies for preparing -alkyl derivatives of 6-substituted-4-(trifluoromethyl)pyrimidin-(1)-ones: a linear protocol of alkylation, using a -building block followed by [3 + 3]-type cyclocondensation with 2-methylisothiourea sulfate and a convergent protocol based on direct alkylation, using 4-(iodomethyl)-2-(methylthio)-6-(trihalomethyl)pyrimidines. It was found that the cyclocondensation strategy is not feasible; thus, the direct chemoselective -alkylation was performed, and 18 derivatives of the targeted pyrimidines were obtained in 70-98% yields. The structure of the products was unambiguously determined via single crystal X-ray analyses and two-dimensional nuclear magnetic resonance experiments.
本研究报道了两种制备6-取代-4-(三氟甲基)嘧啶-(1)-酮的α-烷基衍生物的策略:一种是烷基化的线性方案,使用一个α-结构单元,然后与硫酸2-甲基异硫脲进行[3 + 3]型环缩合;另一种是基于直接烷基化的汇聚方案,使用4-(碘甲基)-2-(甲硫基)-6-(三卤甲基)嘧啶。结果发现环缩合策略不可行;因此,进行了直接化学选择性α-烷基化反应,以70 - 98%的产率得到了18种目标嘧啶衍生物。通过单晶X射线分析和二维核磁共振实验明确确定了产物的结构。